Company Search:
Advanced Search
Sponsored Links
Trans Genic Inc Company Snapshot
Trans Genic Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Trans Genic Inc with three other companies in this sector in Japan: Medical Data Vision Co Ltd (2018 sales of 3.58 billion Japanese Yen [US$32.34 million] ), Japan Tissue Engineering Company Limited (2.27 billion Japanese Yen [US$20.53 million] of which 61% was Regenerative Medicine Products Business), and Symbio Pharmaceuticals Ltd (3.84 billion Japanese Yen [US$34.67 million] ).

Sales Analysis. During the year ended March of 2018, sales at Trans Genic Inc were ¥3.60 billion (US$32.56 million). This is an increase of 56.4% versus 2017, when the company's sales were ¥2.30 billion. This was the fifth consecutive year of sales increases at Trans Genic Inc (and since 2013, sales have increased a total of 411%). Sales of Eliminations and Corporate saw an increase of 112.1% in 2018, from ¥1.65 million to ¥3.50 million. Not all segments of Trans Genic Inc experienced an increase in sales in 2018: sales of Genomics Business fell 29.8% to ¥294.88 million. Trans Genic Inc also experienced decreases in sales in Cro Business (down 13.0% to ¥992.33 million) and Pathological Diagnosis Business (down 0.9% to ¥395.63 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Trans Genic Inc
  Stock Performance Chart for Trans Genic Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 451.00
(Figures in Japanese Yen)
1 Week -7.6%   13 Weeks -7.8%  
4 Weeks -10.9%   52 Weeks -10.9%  
Trans Genic Inc Key Data:
  Ticker: 2342 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,601,283,000
(Year Ending Jan 2019).
Employees: 162
  Currency: Japanese Yen Market Cap: 7,724,601,720
  Fiscal Yr Ends: March Shares Outstanding: 17,127,720
  Share Type: Common Closely Held Shares: 834,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.